Henry Schein Inc

Financials

Flusso di cassa derivante dalle attività operative 204 M37 M120 M174 M381 M 712 M Flussi di cassa derivanti dalle attività di investimento -58 M-99 M-98 M-56 M-147 M -400 M Liquidità derivante dalle attività di finanziamento -204 M89 M56 M-127 M-206 M -188 M Liquidità libera 168 M6 M88 M141 M338 M 573 M

Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world’s largest provider of health care solutions to office-based dental and medical practitioners.

HSIC

Financials

Henry Schein Inc

Notizie

Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term

What to Expect From Henry Schein’s Q1 2026 Earnings Report

Il CdA di Henry Schein si ridurrà a 10 membri dopo l’assemblea annuale

Should You Retain Henry Schein Stock in Your Portfolio for Now?

ISRG's Margins Contract in Q4: Will Tariffs Continue to Hurt in 2026?

Align Technology: Only International Growth Can Save Them Now (Downgrade) (NASDAQ:ALGN)

I migliori titoli di tecnologia medica secondo Piper Sandler

Henry Schein alla Conferenza Barclays: espansione digitale e guadagni di mercato

Henry Schein at Barclays Conference: Digital Expansion and Market Gains

Henry Schein, Inc. (HSIC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Leerink Partners conferma il rating su Henry Schein con target a $87

Leerink Partners reiterates Henry Schein stock rating at $87 target